Lenalidomide as a second‐line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome

Saved in:
Bibliographic Details
Published in:British journal of haematology 2019-09, Vol.186 (5), p.e151-e155
Main Authors: Kim, Hawk, Lee, Je‐Hwan, Lee, Won‐Sik, Kim, Inho, Moon, Joon Ho, Choi, Chul Won, Lee, Ho Sup, Park, Jinny, Choi, Yunsuk, Shin, Ho‐Jin, Cho, Su‐Hee, Kim, Kyoung Ha, Kim, Sung‐Yong, Kim, Yoo‐Jin
Format: Article
Language:English
Subjects:
Hematology
Hypomethylating agent
Immunotherapy
lenalidomide
MDS
Myelodysplastic syndrome
Targeted cancer therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0007-1048
1365-2141
DOI:10.1111/bjh.15991